The International Rare Diseases Research Consortium (Irdirc) has appointed 31 experts to serve on three advisory committees.
Specialists from patients’ organisations, academia and industry will advise Irdirc members on how to maximise the benefits of their spending on rare diseases research.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.